regulation of vascular wound healing / negative regulation of toll-like receptor 5 signaling pathway / negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway / establishment of protein localization to vacuole / tolerance induction to lipopolysaccharide / negative regulation of osteoclast proliferation / negative regulation of CD40 signaling pathway / negative regulation of B cell activation / negative regulation of toll-like receptor 3 signaling pathway / negative regulation of chronic inflammatory response ...regulation of vascular wound healing / negative regulation of toll-like receptor 5 signaling pathway / negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway / establishment of protein localization to vacuole / tolerance induction to lipopolysaccharide / negative regulation of osteoclast proliferation / negative regulation of CD40 signaling pathway / negative regulation of B cell activation / negative regulation of toll-like receptor 3 signaling pathway / negative regulation of chronic inflammatory response / negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway / protein deubiquitination involved in ubiquitin-dependent protein catabolic process / negative regulation of toll-like receptor 2 signaling pathway / positive regulation of protein polyubiquitination / protein K11-linked deubiquitination / nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway / Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase / negative regulation of toll-like receptor 4 signaling pathway / Inactivation of APC/C via direct inhibition of the APC/C complex / APC/C:Cdc20 mediated degradation of mitotic proteins / Aberrant regulation of mitotic exit in cancer due to RB1 defects / B-1 B cell homeostasis / Phosphorylation of the APC/C / protein K48-linked deubiquitination / regulation of defense response to virus by host / Signaling by BMP / (E3-independent) E2 ubiquitin-conjugating enzyme / regulation of tumor necrosis factor-mediated signaling pathway / regulation of germinal center formation / positive regulation of hepatocyte proliferation / 転移酵素; アシル基を移すもの; アミノアシル基を移すもの / hypothalamus gonadotrophin-releasing hormone neuron development / negative regulation of bone resorption / protein K63-linked deubiquitination / TNFR1-induced proapoptotic signaling / female meiosis I / positive regulation of protein monoubiquitination / fat pad development / negative regulation of interleukin-1 beta production / mitochondrion transport along microtubule / negative regulation of interleukin-2 production / E2 ubiquitin-conjugating enzyme / K63-linked deubiquitinase activity / K63-linked polyubiquitin modification-dependent protein binding / female gonad development / seminiferous tubule development / negative regulation of NF-kappaB transcription factor activity / male meiosis I / response to muramyl dipeptide / ubiquitin conjugating enzyme activity / Regulation of APC/C activators between G1/S and early anaphase / negative regulation of interleukin-6 production / positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator / Transcriptional Regulation by VENTX / negative regulation of tumor necrosis factor production / negative regulation of BMP signaling pathway / positive regulation of Wnt signaling pathway / protein deubiquitination / negative regulation of endothelial cell apoptotic process / protein K48-linked ubiquitination / negative regulation of extrinsic apoptotic signaling pathway via death domain receptors / energy homeostasis / regulation of neuron apoptotic process / negative regulation of canonical NF-kappaB signal transduction / negative regulation of TORC1 signaling / regulation of proteasomal protein catabolic process / Maturation of protein E / Maturation of protein E / ER Quality Control Compartment (ERQC) / cytoskeleton organization / Myoclonic epilepsy of Lafora / FLT3 signaling by CBL mutants / negative regulation of protein ubiquitination / Prevention of phagosomal-lysosomal fusion / IRAK2 mediated activation of TAK1 complex / Alpha-protein kinase 1 signaling pathway / Glycogen synthesis / IRAK1 recruits IKK complex / IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation / Membrane binding and targetting of GAG proteins / Endosomal Sorting Complex Required For Transport (ESCRT) / Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 / Negative regulation of FLT3 / PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 / Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation / IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation / Constitutive Signaling by NOTCH1 HD Domain Mutants / NOTCH2 Activation and Transmission of Signal to the Nucleus / TICAM1,TRAF6-dependent induction of TAK1 complex / TICAM1-dependent activation of IRF3/IRF7 / APC/C:Cdc20 mediated degradation of Cyclin B / Regulation of FZD by ubiquitination / Downregulation of ERBB4 signaling / p75NTR recruits signalling complexes / APC-Cdc20 mediated degradation of Nek2A / InlA-mediated entry of Listeria monocytogenes into host cells / TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling / TRAF6-mediated induction of TAK1 complex within TLR4 complex / Regulation of pyruvate metabolism / Regulation of innate immune responses to cytosolic DNA 類似検索 - 分子機能
Tumornecrosisfactoralpha-inducedprotein3 / TNF alpha-induced protein 3 / OTU domain-containing protein 7C / Putative DNA-binding protein A20 / ...TNF alpha-induced protein 3 / OTU domain-containing protein 7C / Putative DNA-binding protein A20 / Zinc finger protein A20
解像度: 3.4→25 Å / Cor.coef. Fo:Fc: 0.876 / Cor.coef. Fo:Fc free: 0.842 / SU B: 102.112 / SU ML: 0.724 / 交差検証法: THROUGHOUT / σ(F): 0 / ESU R Free: 0.767 / 立体化学のターゲット値: MAXIMUM LIKELIHOOD / 詳細: HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS
Rfactor
反射数
%反射
Selection details
Rfree
0.31882
962
10 %
RANDOM
Rwork
0.27984
-
-
-
all
0.284
9612
-
-
obs
0.28381
8650
98.09 %
-
溶媒の処理
イオンプローブ半径: 0.8 Å / 減衰半径: 0.8 Å / VDWプローブ半径: 1.4 Å / 溶媒モデル: MASK
原子変位パラメータ
Biso mean: 94.095 Å2
Baniso -1
Baniso -2
Baniso -3
1-
-3.19 Å2
-1.6 Å2
0 Å2
2-
-
-3.19 Å2
0 Å2
3-
-
-
4.79 Å2
精密化ステップ
サイクル: LAST / 解像度: 3.4→25 Å
タンパク質
核酸
リガンド
溶媒
全体
原子数
3986
0
2
0
3988
拘束条件
Refine-ID
タイプ
Dev ideal
Dev ideal target
数
X-RAY DIFFRACTION
r_bond_refined_d
0.009
0.022
4090
X-RAY DIFFRACTION
r_angle_refined_deg
1.013
1.975
5538
X-RAY DIFFRACTION
r_dihedral_angle_1_deg
5.313
5
494
X-RAY DIFFRACTION
r_dihedral_angle_2_deg
37.848
24.556
180
X-RAY DIFFRACTION
r_dihedral_angle_3_deg
18.909
15
722
X-RAY DIFFRACTION
r_dihedral_angle_4_deg
12.395
15
20
X-RAY DIFFRACTION
r_chiral_restr
0.07
0.2
608
X-RAY DIFFRACTION
r_gen_planes_refined
0.003
0.02
3074
X-RAY DIFFRACTION
r_nbd_refined
0.194
0.2
1669
X-RAY DIFFRACTION
r_nbtor_refined
0.302
0.2
2715
X-RAY DIFFRACTION
r_xyhbond_nbd_refined
0.125
0.2
127
X-RAY DIFFRACTION
r_symmetry_vdw_refined
0.323
0.2
127
X-RAY DIFFRACTION
r_symmetry_hbond_refined
0.208
0.2
5
X-RAY DIFFRACTION
r_mcbond_it
0.834
2.5
2587
X-RAY DIFFRACTION
r_mcangle_it
1.281
5
4086
X-RAY DIFFRACTION
r_scbond_it
1.253
2.5
1707
X-RAY DIFFRACTION
r_scangle_it
1.823
5
1452
Refine LS restraints NCS
Dom-ID: 1 / Refine-ID: X-RAY DIFFRACTION
Ens-ID
Auth asym-ID
数
タイプ
Rms dev position (Å)
Weight position
1
A
588
tightpositional
0.01
0.05
2
B
288
tightpositional
0.02
0.05
3
C
124
tightpositional
0.01
0.05
1
A
582
mediumpositional
0.15
0.5
2
B
286
mediumpositional
0.18
0.5
3
C
125
mediumpositional
0.09
0.5
1
A
588
tightthermal
0.02
0.5
2
B
288
tightthermal
0.02
0.5
3
C
124
tightthermal
0.02
0.5
1
A
582
mediumthermal
0.16
2
2
B
286
mediumthermal
0.15
2
3
C
125
mediumthermal
0.14
2
LS精密化 シェル
解像度: 3.4→3.469 Å / Rfactor Rfree error: 43.6 / Total num. of bins used: 25